Doctors explain what d-mannose is, how it works, and whether it can help prevent recurrent UTIs. Plus, they share other ...

Mo Carrier has dealt with recurrent urinary tract infections, defined as having three or more UTIs per year or two infections ...

Doctors share what the latest research says about preventing UTIs. They give six science-backed tips to prevent a UTI from ...

Panelists discuss how American Urological Association (AUA) guidelines for recurrent uncomplicated urinary tract infections (UTIs) in women recommend culture-confirmed diagnosis, prophylactic ...

Discover 7 research-backed natural remedies for UTI relief, plus foods to avoid. These solutions complement medical care and ...

Panelists discuss how treatment failure in uncomplicated urinary tract infections (UTIs) creates substantial economic burden through direct costs of additional health care visits, repeated diagnostic ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The medication, gepotidacin, targets E. coli bacteria, which is responsible for ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

Neutrophils in urine extrude their DNA to create large webs that catch and kill pathogens.

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new antibiotic to treat urinary tract infections (UTIs). The drug gepotidacin, which will be sold under the ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...